News

The Dose Podcast - Episode 2 "Translating the UNHLM Commitments into Action"

19 Dec 2018
by Working Group
TB Drug R&D Civil Society UN UNHLM advocacy

Episode 2: "Translating the UNHLM Commitments into Action: Ensuring Investment in TB R&D to eliminate TB" 

The second episode of The Dose Podcast will focus on the first ever High-Level Meeting on Tuberculosis held by the United Nations General Assembly and the commitments made there to fight TB. The High-Level Meeting is only the fifth time that the UN in its history has called for a high-level meeting devoted to a health issue.  This podcast will highlight the outcomes resulting from the UNHLM, consider how we can hold countries accountable to their commitments, as well as drive the momentum in development of new TB therapies, vaccines and diagnostics.

Moderator: Bobby Ramakant, Citizen News Service

Speaker: Honorable Nick Herbert, Member of Parliament for Arundel and South Downs in the UK.

Speaker: Blessi Kumar, CEO of the Global Coalition of TB Activists

Listen on Soundcloud: https://soundcloud.com/user-87209407/the-does-podcast-episode-2-translating-the-unhlm-commitments-into-action

More News
19 Mar 2024

Most Robust TB Drug Pipeline in History

For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023

New Tools Summit in Paris this November

The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022

PAN-TB Collaboration Announces Novel TB Drug Regimens Trial

The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...